CDK5 and diabetic kidney disease: The study also highlighted the role of Cdk5-mediated Sirt1 phosphorylation in mitochondrial dysfunction and podocyte injury in diabetic nephropathy, suggesting that targeting the Cdk5-Sirt1 signaling pathway could be a potential therapeutic strategy [47].